NEW YORK, April 23, 2019 /PRNewswire/ -- Koneksa Health, a private company that enables the biopharmaceutical industry to develop new medicines using innovative solutions such as digital biomarkers and novel clinical endpoints, announced today that Steve Hirschfeld has been appointed to the company's board as an independent director.
For more information about Koneksa, please visit http://koneksahealth.com.
Hirschfeld led sales and commercial operations at Medidata Solutions, retiring as Vice Chairman in 2017, after more than 30 years of customer-facing sales and management experience in healthcare and technology. He was on the board of directors of SHYFT Analytics (acquired by Medidata Solutions in 2018) and currently serves as a director for CredSimple.
"Steve's repeated success in driving high growth, and deep expertise in advising health and tech organizations to successfully scale on all fronts, aligns perfectly with Koneksa's goals for the future." said Koneksa CEO Chris Benko. He added, "Steve's leadership qualities, passion for changing healthcare, and tremendous reputation as an engaged director make him an ideal fit for our culture."
"I'm very excited to join Koneksa's board of directors," said Hirschfeld. "The company is positioned to make an enormous difference in the future of clinical trials. I'm pleased to begin working with the board and leadership team to help accelerate their impressive growth. They have proven the ability to make go/no go decisions faster, with fewer patients. That translates to capital efficiency for our clients and reduced patient burden."
About Koneksa Health
Koneksa Health is a private company that enables the biopharmaceutical industry to develop new medicines with fewer patients. By unlocking the potential of real-world data from remote, wearable, and other digital technologies, Koneksa speeds up the time required to understand how a drug is working and helps to develop real-world evidence for how medicines can impact the daily lives of patients.
SOURCE Koneksa Health